Lawrence Berkeley National Laboratory developed a method of detecting preclinical cardiovascular disease that is not only noninvasive, but also affordable and more accurate than some existing technologies. The method was created by Jonathan Maltz and Thomas Budinger, affiliate scientists at Berkeley Lab. According to Maltz, he and Budinger have been working together for more than 20 years, and he has been developing this method since 2009. “It is low-cost, simple and does not need a skilled operator,” Maltz said in an email. “It’s as simple as taking a (blood pressure) measurement wit...